Shabto, Julie M.
Faaborg-Andersen, Christian
O’Keefe, Ghazala A.
Article History
Received: 13 May 2021
Accepted: 18 January 2022
First Online: 5 February 2022
Declarations
:
: This study was conducted as a quality improvement initiative and met criteria for non-human subject research by the Emory University Institutional Review Board. The need for approval was waived by Emory University Institutional Review Board. All methods were carried out in accordance with Emory University’s relevant guidelines and regulations. The informed consent was waived by the Emory University Institutional Review Board.
: The informed consent was waived by the Emory University Institutional Review Board.
: GO served on the advisory board of Eyepoint Pharmaceuticals in 2019, not related to the current work. All other authors declare no conflicts of interest. JMS and CFA declare that they have no competing interests.